ViroPharma surges on buyout; Transocean gains

Shares of ViroPharma Inc. spiked 25.9% Monday in premarket trade after the rare-disease company announced that it was being acquired by U.K. biopharmaceutical firm Shire PLC.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.